Matthew Hobbs
Dr. Matthew Hobbs is the Director of Research at Prostate Cancer UK, where he plays a crucial role in advancing research and awareness around prostate cancer. He commented on the promising outcomes of the NeuroSafe procedure, which aims to reduce erectile dysfunction in men undergoing prostate cancer surgery. Hobbs emphasizes the need for further research to ensure that innovative surgical techniques can be effectively implemented across the NHS for wider patient benefit.
Not in the pool (under ¢1).
Recent news mentions
Matthew Hobbs warns that new technologies must be tested on a larger scale before replacing current methods.
Prueba casera detecta el cáncer de próstata en 15 minutos y con 90% de precisión, según estudio
Colombia· 2025-06-24
Dr. Matthew Hobbs, a geneticist and molecular biologist from the British Prostate Cancer Association, highlights the dangers of unverified therapies and misinformation about cancer.
Oboljeli od raka riskiraju smrt zbog dezinformacija koje čitaju i čuju na ovim mrežama
Croatia· 2025-06-13
Dr Matthew Hobbs described the AI test as 'exciting' and supported the call for abiraterone to be made available to men whose lives it can save.
New AI test can predict which men will benefit from prostate cancer drug | Prostate cancer
United Kingdom· 2025-05-30
Dr Matthew Hobbs, the director of research at Prostate Cancer UK, highlighted the importance of innovative surgery techniques in reducing erectile dysfunction.
Prostate cancer surgery breakthrough offers hope for erectile function | Prostate cancerUnited Kingdom· 2025-03-24